-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of CDE showed that Chengdu Yuandong Biopharmaceutical|Shanxi Pude Pharmaceutical's nicorandil for injection was accepted in imitation 3 categories
Nicorandil cardiovascular system drugs, for the treatment of acute coronary syndrome, angina pectoris, heart failure, unstable angina and the like
Sales of nicorandil for terminal injection in public medical institutions in China in recent years (unit: 100 million yuan)
Source: Mi Nei.
According to data from Minai.
Source: Meinenet MED2.
The only manufacturer of Nicorandil for injection is Beijing Sihuan Kebao Pharmaceutical, which has not been reviewed yet
Source: Meinenet MED2.
Since the beginning of this year, Yuandong Biotech has approved 4 products for the market, all of which are approved for production of 4 types of imitations, which are deemed to have been reviewed
Source: CDE official website, Minet database